Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Gabapentin NDC 50436-5550 by Unit Dose Services, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image 1

image 1

The given text describes a formula for calculating cLcr (creatinine clearance rate) using the age and weight of the patient in kilograms. Additionally, the formula suggests using a different constant factor for female patients. The second part of the formula requires the value of serum creatinine in milligrams per deciliter.*

image 2

image 2

image 3

image 3

image 4

image 4

image 5

image 5

image 6

image 6

The text appears to be a chart or table that shows a mean pain score of 10, along with two treatment options: placebo and gabapentin at a dose of 3600 mg per day. The chart also includes references to a dose titration period and a 4-week fixed dose period, as well as a baseline and multiple weeks. Without additional context, it is not clear what condition or study this chart pertains to.*

image 7

image 7

This appears to be a chart or table related to pain management and medication dosing. It includes columns for the mean pain score, with a score of 0 listed, as well as dose and duration periods for Gabapentin at varying levels (1800 mg/day and 2400 mg/day) over a fixed 4-week period. Beyond that, it is not clear what additional information or context this table is intended to convey.*

image 8

image 8

image 9

image 9

Label Image - lbl504365550

Label Image - lbl504365550

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.